Crossmark

Adenosine in human atrial fibrillation modulates and re-distributes atria-wide dominant frequencies and directs to reentry ablation sites with improved outcome

Crossref DOI link: https://doi.org/10.1038/s41598-025-26262-z

Published Online: 2025-12-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Calvo, David

Salinas, Lucia

Martínez-Camblor, Pablo

Salgado, María

Álvarez-Velasco, Ruth

Martínez-León, Amaia

Soroa, Minel

García-Iglesias, Daniel

Filgueiras-Rama, David

Gonzalez-Ferrer, Juan José

Cañadas, Victoria

Salgado, Ricardo

Cruz, Alba

Quintanilla, Jorge

Redondo, Andrés

Rodrigo, Miguel

Pérez-Villacastín, Julián

Pérez-Castellano, Nicasio

Berenfeld, Omer
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (PI18/01268; PI23/00520)

Heart Rhythm Society of the Spanish Society of Cardiology

National Institutes of Health (R01-HL118304, R21-HL153694, R21-EB032661 and R01-HL156961)
License Information

Text and Data Mining valid from 2025-12-16

Version of Record valid from 2025-12-16
More Information

Article History

Received: 26 February 2025

Accepted: 28 October 2025

First Online: 16 December 2025

Declarations

:

: Dr. Berenfeld is a co-founder of Cor-Dx LLC and has received research grants from Medtronic, Abbott and CoreMap.

Document is current

Any future updates will be listed below